Purchases and Sales Made in Q2 2024 in Calliditas Therapeutics Ab (CALT)
This table provides information about the institutional ownership of Calliditas Therapeutics Ab (CALT) during Q2 2024. The information is specifically focused on institutions that hold shares of Calliditas Therapeutics AB.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2024
Q2 2024
|
Optiver Holding B.V.
Amsterdam, P7 |
BUY
|
- |
19.8K+ 781.45% |
$350K - $820K
|
22.3K
$893K
|
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
BUY
|
- |
10.8KNew |
$190K - $445K
|
10.8K
$430K
|
|
|
Aug 14, 2024
Q2 2024
|
Pender Fund Capital Management Ltd.
Vancouver, A1 |
BUY
|
- |
6KNew |
$106K - $248K
|
6K
$240K
|
|
|
Jul 23, 2024
Q2 2024
|
Global Retirement Partners, LLC
|
BUY
|
- |
500New |
$8.83K - $20.7K
|
500
$20K
|
|
|
Aug 13, 2024
Q2 2024
|
Ever Source Wealth Advisors, LLC
|
BUY
|
- |
125New |
$2.21K - $5.18K
|
125
$5K
|
|
|
Aug 16, 2024
Q2 2024
|
Ironwood Investment Management LLC
Boston, MA |
BUY
|
- |
116+ 0.45% |
$2.05K - $4.8K
|
25.6K
$1.03M
|
|
|
Aug 01, 2024
Q2 2024
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
38+ 23.17% |
$671 - $1.57K
|
202
$8.08K
|
|
|
Aug 09, 2024
Q2 2024
|
Cibc Private Wealth Group, LLC
|
BUY
|
- |
14New |
$247 - $580
|
14
$560
|
|
|
Jul 23, 2024
Q2 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 14, 2024
Q2 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-55- 76.39% |
$971 - $2.28K
|
17
$680
|
|
|
Aug 14, 2024
Q2 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-386- 37.04% |
$6.81K - $16K
|
656
$26.2K
|
|
|
Aug 13, 2024
Q2 2024
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-849- 76.9% |
$15K - $35.2K
|
255
$10.2K
|
|
|
Aug 13, 2024
Q2 2024
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-2.26K- 60.11% |
$39.9K - $93.6K
|
1.5K
$60K
|
|
|
Aug 15, 2024
Q2 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-4.88K- 47.48% |
$86.1K - $202K
|
5.4K
$216K
|
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-5.07K- 84.65% |
$89.4K - $210K
|
919
$36.8K
|
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-5.07K- 84.65% |
$89.4K - $210K
|
919
$36.8K
|